Biotech · Private company · St. Louis, MO, US
Immunophotonics, Inc.
Track this companyFree. Adds Immunophotonics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- 1.0% IP-001 for InjectionPhase 2 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STSPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 29, 2022ClinicalTrials.gov NCT05688280 · fetched Nov 12, 2026
NIH awards1
- Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablationFiscal year 2024 · $780.1KNIH RePORTER 5R44CA257683-03 · fetched Nov 12, 2026